跳到正文
原文
BioPharma Dive· BioPharma Dive's studioID·· 2026-10-06AI 评分19

播客《The Progress Profile: Alzheimer’s Research in Focus》第二季回归,聚焦阿尔茨海默病研究

[Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus

AI 导读

播客《The Progress Profile: Alzheimer’s Research in Focus》第二季回归,在首季基础上继续围绕阿尔茨海默病、脑健康与神经退行性疾病展开四期对话。Dr. Wiesje van der Flier、Maria Carrillo 等嘉宾讨论早期检测、

正文

An article from site logo

Published Oct. 6, 2026

Promotional graphic for Season 2 of The Progress Profile: Alzheimer’s Research in Focus, featuring the Pearson and BioPharma Dive logos on a dark blue background with abstract glowing blue wave patterns on the right.

William Walker/BioPharma Dive

Sponsored content

SPONSORED CONTENT BY

The Progress Profile: Alzheimer’s Research in Focus podcast is back for another season of critical conversations about Alzheimer’s and brain health, building on the conversations from season 1 to learn more about neurodegenerative disease.

Check out the podcast episodes below!

⬆

  1. Ep. 4 Knowing Sooner: Patient Perspective on Risk, Prevention, and Empowerment
  2. Ep. 3 Awareness and Advocacy: Scaling Impact Across Neurogenerative Diseases
  3. Ep. 2 Policy, Equity, and the Expanding Dementia Landscape
  4. Ep. 1 From Trials to Patients—Bridging Science and Lived Experience

Ep. 4

Knowing Sooner: Patient Perspective on Risk, Prevention, and Empowerment

Advances in early detection and prevention are reshaping Alzheimer’s care, but what does this mean for patients and families? In the final episode of this season of The Progress Profile: Alzheimer’s Research in Focus, Dr. Wiesje van der Flier, executive director at Alzheimer Nederland, joins Dr. John Harrison to examine how to better communicate risk and uncertainty, involve patients in decisions about their care, and build a more collaborative approach to tackling Alzheimer’s disease. They also discuss how the growing focus on patient and caregiver perspectives is as critical as larger datasets in shaping the model of how Alzheimer’s research and care progress.

Ep. 3

Awareness and Advocacy: Scaling Impact Across Neurogenerative Diseases

What could earlier detection, blood-based diagnostics, and emerging therapies mean for the future of Alzheimer’s disease? In Episode 3 of The Progress Profile: Alzheimer’s Research in Focus, Maria Carrillo, Ph.D., of the Alzheimer’s Association, joins Dr. John Harrison to explore the scientific advances and critical questions shaping the field. From the promise of prevention to the ethics of early biomarker testing, the conversation examines how progress can translate into meaningful improvements for patients and families. They also tackle misinformation, stigma, and discrimination, and what it takes to advance Alzheimer’s care responsibly.

Ep. 2

Policy, Equity, and the Expanding Dementia Landscape

In Episode 2 of The Progress Profile: Alzheimer’s Research in Focus, Dr. John Harrison, Alzheimer’s disease specialist, welcomes Dr. Phyllis Ferrell, MBA, innovator, investor, and incubator for brain health and longevity. Their conversation explores why scientific progress alone isn't enough to transform dementia care. They also discuss how to improve early diagnosis, the role of inequalities in cognitive health across communities, sex differences in brain health, and how lessons from Alzheimer's disease can advance care and research for other neurodegenerative conditions.

Ep. 1

From Trials to Patients—Bridging Science and Lived Experience

This premier episode of The Progress Profile: Alzheimer’s Research in Focus podcast brings together Dr. John Harrison, Dr. Lon Schneider, and Dr. Stephen Salloway as they discuss how to bridge the gap between clinical trial design and frontline care, exploring how insights from Alzheimer’s research are informing more patient-centered approaches to treatment, measurement, and long-term disease management.

来源:BioPharma Dive · biopharmadive.com